Drug facts
MoleculeFurosemide (Lasix Onyu)
Generics already compete: 20 makers on the market. 30 A-rated products from 20 makers substitute at the counter.
Lasix was first approved by the FDA before 1982 under NDA 016273; the application holder is Validus Pharmaceuticals LLC. The Orange Book lists NDA 016273 as discontinued.
Furosemide is on the current FDA drug shortage list, first posted 04/07/2020.
Holder Validus Pharmaceuticals LLCApplication NDA 016273Approved before 1982
01Patents and exclusivity
When competition can legally begin. A generic can launch once both exclusivity and the last listed patent expire, unless a court or settlement says otherwise.
- Latest patent
- No Lasix patent listed in the Orange Book Orange Book
- Later patents, other products
- Lasix Onyu 01/10/2042; Furoscix 01/30/2040 Orange Book
02Competition
- Generics
- 20 generic makers Orange Book
- First generic approved
- 09/09/1985 Orange Book
Every listingEach listing and maker behind the generics count.
Price erosionHow NADAC moves as generics enter.
PrescribersWho prescribes it, from Medicare data.
Available in the full Furosemide profile.See what is included
03Supply and price
- FDA drug shortage
- ActiveOn the current shortage listsince 04/07/2020, available FDA shortages
- NADAC
- $0.26 per mLFUROSEMIDE 40 MG/4 ML VIAL, mid-priced of 4 strengths, as of 10/28/2026 CMS NADAC
- Latest recall
- 03/20/2026Class II, Furosemide, Leading Pharma, LLC FDA enforcement
04Product
- Application holder
- Validus Pharmaceuticals LLC Orange Book
- Application
- NDA 016273 Orange Book
- First approved
- before 1982 Orange Book
- Dosage forms
- injectable; solution; tablet
- Routes
- injection, oral, subcutaneous
- Other brand names
- Furoscix
- Status
- NDA 016273 discontinued Orange Book
Sources: FDA Orange Book, FDA Purple Book, FDA drug shortages, FDA enforcement reports and CMS NADAC, read through QOPE. Not medical or legal advice.